Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 18 studies | 43% ± 21% | |
| endothelial cell | 17 studies | 42% ± 18% | |
| ciliated cell | 14 studies | 35% ± 16% | |
| oligodendrocyte precursor cell | 14 studies | 63% ± 16% | |
| microglial cell | 13 studies | 49% ± 17% | |
| glutamatergic neuron | 12 studies | 86% ± 12% | |
| oligodendrocyte | 12 studies | 44% ± 15% | |
| GABAergic neuron | 11 studies | 78% ± 18% | |
| neuron | 9 studies | 55% ± 21% | |
| mast cell | 9 studies | 36% ± 16% | |
| amacrine cell | 8 studies | 58% ± 24% | |
| pericyte | 8 studies | 35% ± 14% | |
| smooth muscle cell | 8 studies | 34% ± 20% | |
| macrophage | 7 studies | 34% ± 15% | |
| retinal cone cell | 7 studies | 72% ± 22% | |
| retinal rod cell | 7 studies | 48% ± 28% | |
| fibroblast | 7 studies | 33% ± 13% | |
| interneuron | 6 studies | 88% ± 10% | |
| retinal ganglion cell | 6 studies | 54% ± 28% | |
| retina horizontal cell | 6 studies | 52% ± 32% | |
| retinal bipolar neuron | 5 studies | 52% ± 27% | |
| cardiac muscle cell | 5 studies | 52% ± 14% | |
| mesothelial cell | 5 studies | 43% ± 12% | |
| Mueller cell | 5 studies | 60% ± 28% | |
| type I pneumocyte | 5 studies | 21% ± 1% | |
| type II pneumocyte | 5 studies | 22% ± 4% | |
| epithelial cell | 4 studies | 43% ± 11% | |
| granule cell | 4 studies | 81% ± 11% | |
| retinal pigment epithelial cell | 4 studies | 61% ± 23% | |
| respiratory goblet cell | 4 studies | 46% ± 20% | |
| endothelial cell of lymphatic vessel | 4 studies | 24% ± 4% | |
| club cell | 4 studies | 45% ± 17% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 56% ± 5% | |
| GABAergic interneuron | 3 studies | 85% ± 11% | |
| glial cell | 3 studies | 31% ± 8% | |
| progenitor cell | 3 studies | 47% ± 26% | |
| GABAergic amacrine cell | 3 studies | 87% ± 13% | |
| OFF-bipolar cell | 3 studies | 70% ± 29% | |
| ON-bipolar cell | 3 studies | 70% ± 29% | |
| glycinergic amacrine cell | 3 studies | 75% ± 18% | |
| rod bipolar cell | 3 studies | 72% ± 21% | |
| basal cell | 3 studies | 33% ± 18% | |
| ependymal cell | 3 studies | 60% ± 12% | |
| plasma cell | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 2056.37 | 245 / 245 | 95% | 9.74 | 476 / 502 |
| brain | 97% | 3583.52 | 2564 / 2642 | 96% | 11.82 | 677 / 705 |
| thymus | 100% | 1785.80 | 652 / 653 | 91% | 9.38 | 548 / 605 |
| adrenal gland | 100% | 1803.40 | 258 / 258 | 81% | 16.06 | 186 / 230 |
| kidney | 99% | 987.47 | 88 / 89 | 80% | 5.80 | 719 / 901 |
| breast | 99% | 1378.46 | 455 / 459 | 78% | 6.29 | 867 / 1118 |
| pancreas | 89% | 641.20 | 292 / 328 | 71% | 4.80 | 126 / 178 |
| uterus | 99% | 2539.30 | 169 / 170 | 35% | 2.70 | 161 / 459 |
| skin | 66% | 514.46 | 1191 / 1809 | 68% | 4.73 | 319 / 472 |
| lung | 79% | 604.00 | 458 / 578 | 51% | 2.95 | 584 / 1155 |
| bladder | 100% | 2368.57 | 21 / 21 | 24% | 1.39 | 122 / 504 |
| esophagus | 78% | 1661.37 | 1131 / 1445 | 35% | 1.79 | 64 / 183 |
| ovary | 100% | 2069.83 | 180 / 180 | 13% | 0.45 | 56 / 430 |
| intestine | 92% | 2439.73 | 892 / 966 | 17% | 0.82 | 92 / 527 |
| stomach | 80% | 1302.44 | 288 / 359 | 24% | 1.54 | 69 / 286 |
| spleen | 100% | 949.14 | 240 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1564.76 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 95% | 880.04 | 1143 / 1204 | 0% | 0 | 0 / 0 |
| heart | 90% | 1599.92 | 773 / 861 | 0% | 0 | 0 / 0 |
| muscle | 86% | 620.93 | 691 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 0.77 | 7 / 29 |
| eye | 0% | 0 | 0 / 0 | 20% | 0.85 | 16 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.56 | 7 / 45 |
| liver | 0% | 2.08 | 1 / 226 | 10% | 0.51 | 42 / 406 |
| peripheral blood | 3% | 21.43 | 30 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008104 | Biological process | protein localization |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0019901 | Molecular function | protein kinase binding |
| Gene name | NBEA |
| Protein name | Neurobeachin Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) |
| Synonyms | BCL8B KIAA1544 LYST2 |
| Description | FUNCTION: Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the membrane. May anchor the kinase to cytoskeletal and/or organelle-associated proteins (By similarity). . |
| Accessions | A0A8I5KSX3 A0A8I5KQP5 ENST00000537702.6 [Q8NFP9-3] ENST00000685686.1 [Q8NFP9-3] A0A8I5QJQ0 ENST00000688422.1 ENST00000686647.1 ENST00000687287.1 ENST00000400445.8 [Q8NFP9-1] ENST00000693262.1 [Q8NFP9-3] ENST00000685987.1 A0A8I5KXY8 ENST00000692464.1 ENST00000689454.1 [Q8NFP9-3] ENST00000693547.1 ENST00000691196.1 A0A8I5QKR6 A0A8I5KZ13 ENST00000685329.1 [Q8NFP9-3] ENST00000692578.1 A0A8I5KXR7 A0A8I5KS58 ENST00000692628.1 Q5T321 ENST00000685991.1 A0A8I5KWL1 A0A8I5KQL6 ENST00000693735.1 A0A8I5KX92 ENST00000688363.1 A0A8I5KTY1 ENST00000691351.1 A0A0D9SF28 ENST00000690976.1 ENST00000686741.1 [Q8NFP9-3] ENST00000686320.1 A0A8I5KXL4 ENST00000379939.7 A0A8I5KRZ1 Q8NFP9 A0A8I5KS18 ENST00000688335.1 ENST00000686972.1 A0A8I5KXW8 ENST00000461581.2 A0A8I5QJB2 ENST00000688626.1 ENST00000691561.1 ENST00000629018.4 A0A8I5KTV6 ENST00000690712.1 A0A8I5KRX1 ENST00000686952.1 [Q8NFP9-3] A0A8I5QKR1 |